The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitations
Abstract
OBJECTIVE: The use of procalcitonin (ProCT) as a marker of several clinical conditions, in particular, systemic inflammation, infection, and sepsis, will be clarified, and its current limitations will be delineated. In particular, the need for a more sensitive assay will be emphasized. For these purposes, the medical literature comprising clinical studies pertaining to the measurement of serum ProCT in various clinical settings was examined. DATA SOURCE AND SELECTION: A PubMed search (1965 through November 2007) was conducted, including manual cross-referencing. Pertinent complete publications were obtained using the MeSH terms procalcitonin, C-reactive protein, sepsis, and biological markers. Textbook chapters were also read and extracted. DATA EXTRACTION AND SYNTHESIS: Available clinical and other patient data from these sources were reviewed, including any data relating to precipitating factors, clinical findings, associated illnesses, and patient outcome. Published data concerning sensitivity, specificity, and reproducibility of ProCT assays were reviewed. CONCLUSIONS: Based on available data, the measurement of serum ProCT has definite utility as a marker of severe systemic inflammation, infection, and sepsis. However, publications concerning its diagnostic and prognostic utility are contradictory. In addition, patient characteristics and clinical settings vary markedly, and the data have been difficult to interpret and often extrapolated inappropriately to clinical usage. Furthermore, attempts at meta-analyses are greatly compromised by the divergent circumstances of reported studies and by the sparsity and different timing of the ProCT assays. Although a high ProCT commonly occurs in infection, it is also elevated in some noninfectious conditions. Thus, the test is not a specific indicator of either infection or sepsis. Moreover, in any individual patient, the precipitating cause of an illness, the clinical milieu, and complicating conditions may render tenuous any reliable estimations of severity or prognosis. It also is apparent that even a febrile septic patient with documented bacteremia may not necessarily have a serum ProCT that is elevated above the limit of functional sensitivity of the assay. In this regard, the most commonly applied assay (i.e., LUMItest) is insufficiently sensitive to detect potentially important mild elevations or trends. Clinical studies with a more sensitive ProCT assay that is capable of rapid and practicable day-to-day monitoring are needed and shortly may be available. In addition, investigations showing that ProCT and its related peptides may have mediator relevance point to the need for evaluating therapeutic countermeasures and studying the pathophysiologic effect of hyperprocalcitonemia in serious infection and sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
Rangel-Frausto, M. S. (1995) · JAMA · doi:10.1001/jama.273.2.117 · Cited by 2,104
Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P., & Lacroix, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421997 · Cited by 1,787
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Procalcitonin increase after endotoxin injection in normal subjects
Dandona, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1605 · Cited by 965
Tang, B. M., Eslick, G. D., Craig, J. C., & McLean, A. S. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70052-x · Cited by 851
Uzzan, B., Cohen, R., Nicolas, P., Cucherat, M., & Perret, G.-Y. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000226413.54364.36 · Cited by 738
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Self-citationBecker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Self-citationParikh, C. R., Abraham, E., Ancukiewicz, M., & Edelstein, C. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030236 · Cited by 563
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
Dear SIRS, I'm sorry to say that I don't like you
Vincent, J.-L. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00029 · Cited by 444
Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis1
Müller, B., White, J. C., Nylén, E. S., Snider, R. H., Becker, K. L., & Habener, J. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7089 · Cited by 440
Self-citationComparison of procalcitonin and C-reactive protein as markers of sepsis
Luzzani, A., Polati, E., Dorizzi, R., Rungatscher, A., Pavan, R., & Merlini, A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000063440.19188.ed · Cited by 425
Castelli, G. P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D., & Sgarbi, L. (2004) · Critical Care · doi:10.1186/cc2877 · Cited by 417
Procalcitonin used as a marker of infection in the intensive care unit
Ugarte, H., Silva, E., Mercan, D., De Mendonca, A., & Vincent, J.-L. (1999) · Critical Care Medicine · doi:10.1097/00003246-199903000-00024 · Cited by 415
de Werra, I., Jaccard, C., Corradin, S. B., Chiolero, R., Yersin, B., Gallati, H., Assicot, M., Bohuon, C., Baumgartner, J.-D., Glauser, M. P., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199704000-00009 · Cited by 388
Procalcitonin increase in early identification of critically ill patients at high risk of mortality*
Jensen, J. U., Heslet, L., Jensen, T. H., Espersen, K., Steffensen, P., & Tvede, M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000239116.01855.61 · Cited by 380
Postoperative plasma concentrations of procalcitonin after different types of surgery
Meisner, M., Tschaikowsky, K., Hutzler, A., Schüttler, J., & Schick, C. (1998) · Intensive Care Medicine · doi:10.1007/s001340050644 · Cited by 343
Nylen, E. S., Whang, K. T., Snider, R. H., Steinwald, P. M., White, J. C., & Becker, K. L. (1998) · Critical Care Medicine · doi:10.1097/00003246-199806000-00015 · Cited by 327
Self-citationMeisner, M., Tschaikowsky, K., Palmaers, T., & Schmidt, J. (1999) · Critical Care · doi:10.1186/cc306 · Cited by 326
Procalcitonin as an early marker of infection in neonates and children
van Rossum, A., Wulkan, R., & Oudesluys-Murphy, A. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01146-6 · Cited by 310
Postoperative plasma concentrations of procalcitonin after different types of surgery
Meisner, M., Tschaikowsky, K., Hutzler, A., Schick, C., & Schmidt, J. (1998) · Critical Care · doi:10.1186/cc170 · Cited by 308
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
Luyt, C.-E., Guérin, V., Combes, A., Trouillet, J.-L., Ayed, S. B., Bernard, M., Gibert, C., & Chastre, J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-746oc · Cited by 288
Burns, Bacterial Translocation, Gut Barrier Function, and Failure
Magnotti, L. J., & Deitch, E. A. (2005) · Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000176878.79267.e8 · Cited by 277
Wanner, G. A., Keel, M., Steckholzer, U., Beier, W., Stocker, R., & Ertel, W. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00007 · Cited by 263
Diagnostic and prognostic value of procalcitonin in patients with septic shock
Clec’h, C., Ferriere, F., Karoubi, P., Fosse, J. P., Cupa, M., Hoang, P., & Cohen, Y. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000126263.00551.06 · Cited by 233
Gibot, S., Cravoisy, A., Kolopp-Sarda, M.-N., Béné, M.-C., Faure, G., Bollaert, P.-E., & Levy, B. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000159089.16462.4a · Cited by 232
Meisner, M., Adina, H., & Schmidt, J. (2005) · Critical Care · doi:10.1186/cc3910 · Cited by 231
Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit
Balci, C., Sungurtekin, H., Gürses, E., Sungurtekin, U., & Kaptanoğlu, B. (2002) · Critical Care · doi:10.1186/cc1843 · Cited by 225
Puder, J. J., Varga, S., Kraenzlin, M., De Geyter, C., Keller, U., & Müller, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1002 · Cited by 216
GENETIC POLYMORPHISMS AND SEPSIS
Arcaroli, J., Fessler, M. B., & Abraham, E. (2005) · Shock · doi:10.1097/01.shk.0000180621.52058.e1 · Cited by 210
Chirouze, C., Schuhmacher, H., Rabaud, C., Gil, H., Khayat, N., Estavoyer, J., May, T., & Hoen, B. (2002) · Clinical Infectious Diseases · doi:10.1086/341023 · Cited by 205
Mitaka, C. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.08.018 · Cited by 195
Sponholz, C., Sakr, Y., Reinhart, K., & Brunkhorst, F. (2006) · Critical Care · doi:10.1186/cc5067 · Cited by 179
Sevransky, J., Levy, M. M., & Marini, J. J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145947.19077.25 · Cited by 173
Procalcitonin: a valuable indicator of infection in a medical ICU?
Suprin, E., Camus, C., Gacouin, A., Le Tulzo, Y., Lavoue, S., Feuillu, A., & Thomas, R. (2000) · Intensive Care Medicine · doi:10.1007/s001340000580 · Cited by 168
Procalcitonin and its Component Peptides in Systemic Inflammation: Immunochemical Characterization
Snider, R. H., Nylen, E. S., & Becker, K. L. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500911 · Cited by 166
Self-citationGaïni, S., Koldkjær, O. G., Pedersen, C., & Pedersen, S. S. (2006) · Critical Care · doi:10.1186/cc4866 · Cited by 162
Serum Calcitonin Precursors in Sepsis and Systemic Inflammation1
Whang, K. T., Steinwald, P. M., White, J. C., Nylen, E. S., Snider, R. H., Simon, G. L., Goldberg, R. L., & Becker, K. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5129 · Cited by 161
Self-citationFRANZ, A. R., KRON, M., POHLANDT, F., & STEINBACH, G. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199908000-00003 · Cited by 159
Carsin, H., Assicol, M., Féger, F., et al. (1997) · Burns · doi:10.1016/s0305-4179(96)00124-6 · Cited by 155
Suffredini, A. F., Hochstein, H. D., & McMahon, F. G. (1999) · The Journal of Infectious Diseases · doi:10.1086/314717 · Cited by 154
Procalcitonin as a marker of bacterial infection in the emergency department: an observational study
Chan, Y., Tseng, C., Pei-Kuei, T., Chang, S.-S., Chiu, T., & Chen, J.-C. (2003) · Critical Care · doi:10.1186/cc2396 · Cited by 150
Giamarellos‐Bourboulis, E. J., Mega, A., Grecka, P., Scarpa, N., Koratzanis, G., Thomopoulos, G., & Giamarellou, H. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1398-z · Cited by 148
Lack of specificity of procalcitonin for sepsis diagnosis in premature infants
Lapillonne, A., Basson, É., Monneret, G., Bienvenu, J., & Salle, B. L. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79165-0 · Cited by 147
von Lilienfeld‐Toal, M., Dietrich, M. P., Glasmacher, A. G., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1156-y · Cited by 146
Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome
Arkader, R. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2005.077446 · Cited by 144
Boussekey, N., Leroy, O., Georges, H., Devos, P., d’Escrivan, T., & Guery, B. P. (2005) · Infection · doi:10.1007/s15010-005-4096-2 · Cited by 139
Increased gut permeability early after burns correlates with the extent of burn injury
Ryan, C. M., Yarmush, M. L., Burke, J. F., & Tompkins, R. G. (1992) · Critical Care Medicine · doi:10.1097/00003246-199211000-00005 · Cited by 110
Procalcitonin as a Diagnostic Aid in Osteomyelitis and Septic Arthritis
Butbul‐Aviel, Y., Koren, A., Halevy, R., & Sakran, W. (2005) · Pediatric Emergency Care · doi:10.1097/01.pec.0000190226.12610.24 · Cited by 107
Wagner, K. E., Martinez, J. M., Vath, S. D., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200210000-00021 · Cited by 107
Intensive-coronary-care units.
Hutton, I., Pack, A. I., Rm, L., & Lawrie, T. D. V. (1970) · PubMed · Cited by 102
Stryjewski, G. R., Nylen, E. S., Bell, M. J., Snider, R. H., Becker, K. L., Wu, A. Y., Lawlor, C., & Dalton, H. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000149317.15274.48 · Cited by 100
Self-citationBossink, A. W. J., Groeneveld, A. B. J., & THIJS, L. G. (1999) · Clinical Infectious Diseases · doi:10.1086/520222 · Cited by 98
Kinasewitz, G. T., Zein, J., Lee, G. L., Nazir, S. A., & Taylor, F. B. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181296.53204.de · Cited by 96
Procalcitonin as a marker of severity in septic shock
Schröder, J., Staubach, K.-H., Zabel, P., et al. (1999) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050170 · Cited by 94
Martinot, M., Sordet, C., Soubrier, M., Puéchal, X., Saraux, A., Lioté, F., Guggenbuhl, P., Legré-Boyer, V., Jaulhac, B., Maillefert, J.-F., et al. (2005) · PubMed · Cited by 92
The birth process initiates an acute phase reaction in the fetus-newborn infant
Marchini, G., Berggren, V., Merzoug, R. D., & Hansson, L. ‐. (2000) · Acta Paediatrica · doi:10.1080/713794557 · Cited by 90
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia
Schleicher, G. K., Herbert, V. D., Brink, A. J., Martin, S., Maraj, R., Galpin, J. S., & Feldman, C. H. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00067604 · Cited by 86
Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® System
Steinbach, G., Rau, B., Debard, A., Javourez, J.-F., Bienvenu, J., Ponzio, A., Bonfà, A., Hubl, W., Demant, T., Külpmann, W.-R., et al. (2004) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2004.077 · Cited by 83
Procalcitonin is a Valuable Prognostic Marker in Cardiac Surgery but not Specific for Infection
Dörge, H., Schöndube, F., Dörge, P., et al. (2003) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2003-45425 · Cited by 80
Is procalcitonin useful in early diagnosis of serious bacterial infections in children?
Thayyil, S., Shenoy, M., Hamaluba, M., et al. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01883.x · Cited by 80
Hensler, T., Sauerland, S., Lefering, R. L., Nagelschmidt, M., Bouillon, B., Andermahr, J., & Neugebauer, E. A. M. (2003) · Shock · doi:10.1097/01.shk.0000093541.78705.38 · Cited by 79
Serum procalcitonin concentrations in acute malaria
Davis, T. M. E., Assicot, M., Bohuon, C., John, A. S., Li, G. Q., & Anh, T. K. (1994) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(94)90221-6 · Cited by 79
Preas, H. L., Nylén, E., Snider, R. H., Becker, K. L., White, J. C., Agosti, J. M., & Suffredini, A. F. (2001) · The Journal of Infectious Diseases · doi:10.1086/322031 · Cited by 76
Self-citationWunder, C., Eichelbr�nner, O., & Roewer, N. (2004) · Inflammation Research · doi:10.1007/s00011-003-1239-3 · Cited by 75
Laboratory Markers of Severe Acute Pancreatitis
Rau, B., Schilling, M. K., & Beger, H. G. (2004) · Digestive Diseases · doi:10.1159/000082796 · Cited by 75
CALCITONIN HETEROGENEITY IN LUNG CANCER AND MEDULLARY THYROID CANCER
Becker, K. L., Snider, R. H., Silva, O. L., & Moore, C. F. (1978) · European Journal of Endocrinology · doi:10.1530/acta.0.0890089 · Cited by 73
Self-citationCharles, P., Dalle, F., Aho, S., Quenot, J., Doise, J., Aube, H., Olsson, N., & Blettery, B. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0306-3 · Cited by 71
Tight control of glycaemia in critically ill patients
Preiser, J., Devos, P., & den Berghe, G. V. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00012 · Cited by 70
van Langevelde, P., Joop, K., van Loon, J., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317480 · Cited by 70
Kocazeybek, B., Küçükoğlu, S., & Öner, Y. A. (2003) · Chemotherapy · doi:10.1159/000069777 · Cited by 69
The Future Diagnostic Role of Procalcitonin Levels: The Need for Improved Sensitivity
Nylén, E., Müller-Stich, B. P., Becker, K. L., & Snider, R. H. (2003) · Clinical Infectious Diseases · doi:10.1086/368088 · Cited by 66
Self-citationGiamarellos‐Bourboulis, E. J., Giannopoulou, P. C., Grecka, P., Voros, D., Mandragos, K. E., & Giamarellou, H. (2004) · Journal of Critical Care · doi:10.1016/j.jcrc.2004.07.001 · Cited by 65
Shimetani, N. (2001) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/003655101753218337 · Cited by 65
Ren, J. T. (2006) · Frontiers in bioscience · doi:10.2741/1776 · Cited by 64
Calcitonin Precursors: Early Markers of Gut Barrier Dysfunction in Patients With Acute Pancreatitis
Ammori, B. J., Becker, K. L., Kite, P., Snider, R. H., Nylen, E. S., White, J. C., Barclay, G. R., Larvin, M., & McMahon, M. J. (2003) · Pancreas · doi:10.1097/00006676-200310000-00008 · Cited by 59
Self-citationSepsis, SIRS, and MODS: What’s in a Name?
Nathens, A. B., & Marshall, J. C. (1996) · World Journal of Surgery · doi:10.1007/s002689900061 · Cited by 58
Briel, M., Christ‐Crain, M., Young, J., Schüetz, P., Huber, P., Périat, P., Bucher, H. C., & Müller-Stich, B. P. (2005) · BMC Family Practice · doi:10.1186/1471-2296-6-34 · Cited by 54
Procalcitonin: A Marker of Bacteraemia in SIRS
Bell, K., Wattie, M., Byth, K., et al. (2003) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0303100603 · Cited by 53
Alterations in Cell Signaling in Sepsis
Abraham, E. H. (2005) · Clinical Infectious Diseases · doi:10.1086/431997 · Cited by 53
Hauser, B., Kick, J., Asfar, P., Ehrmann, U., Albicini, M., Vogt, J. A., Wachter, U. A., Brückner, U. B., Fink, M. P., Radermacher, P., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178177.03979.ce · Cited by 52
Petrikkos, G. L., Christofilopoulou, S., Tentolouris, N., Charvalos, E., Kosmidis, C., & Daikos, G. L. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1312-z · Cited by 49
Serum Procalcitonin Differentiates Inflammatory Bowel Disease and Self-limited Colitis
Herrlinger, K. R., Dittmann, R., Weitz, G., Wehkamp, J., Ludwig, D., Schwab, M. G., Stange, E. F., & Fellermann, K. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200405000-00008 · Cited by 48
Surgery for mesenteric infarction: Prognostic factors associated with early death within 72 hours
Merle, C., Lepouse, C., De Garine, A., Frayssinet, N., Leymarie, F., Leon, A., & Jolly, D. (2004) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2004.08.011 · Cited by 47
Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis
Viallon, A., Guyomarch, P., Guyomarch, S., Tardy, B., Robert, F., Marjollet, O., Caricajo, A., Lambert, C., Zéni, F., & Bertrand, J.-C. (2005) · Critical Care · doi:10.1186/cc3722 · Cited by 46
Egger, G., Aigner, R., Glasner, A., Hofer, H. P., Mitterhammer, H., & Zelzer, S. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2111-6 · Cited by 45
Immunoneutralization of procalcitonin as therapy of sepsis
Becker, K., Nylen, E. S., Snider, R., Müller-Stich, B. P., & White, J. C. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090061001 · Cited by 44
Self-citationDomenech, V. S., Nylén, E., White, J. C., Snider, R. H., Becker, K. L., Landmann, R. M., & Müller-Stich, B. P. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.33628 · Cited by 44
Self-citationCalcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission
Ammori, B. J., Becker, K. L., Kite, P., Snider, R. H., Nylen, E. S., White, J. C., Larvin, M., & McMahon, M. J. (2003) · British journal of surgery · doi:10.1002/bjs.4036 · Cited by 43
Self-citationPrognostic value of procalcitonin in children with meningococcal sepsis
Carrol, E. D., Newland, P., Thomson, A. P. J., & Hart, C. A. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000150742.57817.ee · Cited by 42
Increased Serum Procalcitonin Levels Are Not Specific to Sepsis in Neonates
Monneret, G., Labaune, J. M., Isaac, C., Bienvenu, F., Putet, G., & Bienvenu, J. (1998) · Clinical Infectious Diseases · doi:10.1086/517758 · Cited by 39
Procalcitonin in severe acute respiratory syndrome (SARS)
Chua, A. P., & Lee, K. H. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.01.015 · Cited by 30
Takahashi, K., Kita, E., Konishi, M., Yoshimoto, E., Mikasa, K., Narita, N., & Kimura, H. (2003) · Microbial Pathogenesis · doi:10.1016/j.micpath.2003.06.001 · Cited by 28
Casado‐Flores, J., Blanco-Quirós, A., Nieto‐Moro, M., Asensio, J., & Fernández, C. (2005) · European Journal of Pediatrics · doi:10.1007/s00431-005-1761-5 · Cited by 25
Lee, Y. J., Park, C. H., Yun, J. W., & Lee, Y. S. (2004) · Yonsei Medical Journal · doi:10.3349/ymj.2004.45.1.29 · Cited by 22
Braun, N., Marfo, Y., Gärtner, C. V., Burchard, G. D., Zipfel, P. F., Browne, N. E. N., Fleischer, B., & Bröker, B. M. (2003) · Tropical Medicine & International Health · doi:10.1046/j.1360-2276.2003.01128.x · Cited by 21
N-Procalcitonin: Central Effects on Feeding and Energy Homeostasis in Rats
Tavares, E., Maldonado, R., & Miñano, F. J. (2006) · Endocrinology · doi:10.1210/en.2006-0792 · Cited by 14
Improving outcomes in septic shock—Can we define causality and find more efficacious treatments?*
Mongan, P. D. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000178286.94841.ec · Cited by 1
Cited by
Pierrakos, C., & Vincent, J.-L. (2010) · Critical Care · doi:10.1186/cc8872 · Cited by 1,377
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
de Jong, E., van Oers, J. A., Beishuizen, A., Vos, P., Vermeijden, W. J., Haas, L. E., Loef, B. G., Dormans, T., van Melsen, G. C., Kluiters, Y. C., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00053-0 · Cited by 836
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
Stearns-Kurosawa, D. J., Osuchowski, M. F., Valentine, C., Kurosawa, S., & Remick, D. G. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130327 · Cited by 549
Metadata
- Authors
- Becker, K. L., Snider, R., & Nylen, E. S.
- Venue
- Critical Care Medicine
- Published
- 2008-03
- Volume
- 36
- Issue
- 3
- Pages
- 941-952
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2032468128
- Cited by
- 598
- References
- 103
- FWCI
- 26.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.